| 注册
首页|期刊导航|中国医学创新|依那普利联合倍他乐克对高血压的疗效观察

依那普利联合倍他乐克对高血压的疗效观察

王东江 徐萍

中国医学创新Issue(18):41-42,43,3.
中国医学创新Issue(18):41-42,43,3.DOI:10.3969/j.issn.1674-4985.2015.18.015

依那普利联合倍他乐克对高血压的疗效观察

Efficacy Observation of Enalapril Combined with Betaloc in the Treatment of Hypertension

王东江 1徐萍2

作者信息

  • 1. 广州市干部疗养院 广东 广州 510530
  • 2. 哈尔滨医科大学附属第二医院
  • 折叠

摘要

Abstract

Objective:To investigate the clinical efficacy of Enalapril combined with Betaloc in the treatment of hypertension.Method:98 cases of hypertension patients in our hospital were selected as the study objects,they were randomly divided into the observation group and the control group,49 cases in each group.Patients in the control group were given extended release nifedipine tablets treatment,the observation group was treated with Enalapril and Betaloc.The clinical efficacy of the two groups were analyzed.Result:The total effective rate of the observation group was significantly higher than that of the control group (P<0.05).The adverse reactions rate of the observation group was significantly lower than that of the control group(P<0.05). The blood pressure of the two groups had no significant difference before treatment(P>0.05).After the treatment,the situation of the two groups were both improved,but the improvement of the observation group was much better than that of the control group (P<0.05).Conclusion:Using Enalapril combined with Betaloc in the treatment of hypertension can be effectively and improve patients’ blood pressure.It has high security and should be popularized and applied.

关键词

依那普利/倍他乐克/高血压

Key words

Enalapril/Betaloc/Hypertension

引用本文复制引用

王东江,徐萍..依那普利联合倍他乐克对高血压的疗效观察[J].中国医学创新,2015,(18):41-42,43,3.

基金项目

黑龙江省卫生计生委科研课题 ()

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文